For FDA-approved GLP-1 medications, contraindications include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and a history of severe allergic reaction to the drug
These injections are now being promoted as a general solution for: stubborn weight slow metabolism appetite struggles emotional eating repeated dieting failure And that is where we need to pause
A consumer patch offers neither a proven route across the skin nor a verified dose, which is the core reason clinicians do not treat patches as equivalent to a regulated GLP-1 medication
it also triggers hormonal changes (independent of GLP-1 drugs) that reset metabolism, reduce appetite, and often lead to the remission of type 2 diabetes
They may adjust your dose or suggest an alternative treatment
Its a strong fit for people who want medical treatment with flexibility